Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2001Current Medical Research and Opinion

A New Therapeutic Target in Alzheimer's Disease Treatment: Attention to Butyrylcholinesterase

View Full Paper
Ask AI
Bookmark
Share

Authors

NGNigel H. GreigNational Institutes of HealthTUTada UtsukiUtsunomiya UniversityQYQian-sheng YuNational Institutes of Health

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Greig et al. (2001) studied this question.

synapsesocial.com/papers/6a93eaa6219df916ad43e389https://doi.org/10.1185/0300799039117057
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Maze learning in aged rats is enhanced by phenserine, a novel anticholinesterase1995 · 45 citations
  2. 2Acetylcholinesterase: enzyme structure, reaction dynamics, and virtual transition states1987 · 1,083 citations
  3. 3Phenserine regulates translation of β-amyloid precursor protein mRNA by a putative interleukin-1 responsive element, a target for drug development2001 · 209 citations
  4. 4Distribution of butyrylcholinesterase in the human amygdala and hippocampal formation1998 · 169 citations
  5. 5Synthesis of Novel Phenserine-Based-Selective Inhibitors of Butyrylcholinesterase for Alzheimer's Disease1999 · 212 citations